Malaria prophylaxis. Effects and side-effects of antimalarial agents;MALARIAPROFYLAKSE. VIRKNINGER OG BIVIRKNINGER AF FARMAKA DER BRUGES TIL FOREBYGGELSE AF MALARIA

Ugeskrift for Laeger

Volumn 159, Issue 18, 1997, Pages 2723-2730

  Petersen, Eskild ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; CHLOROQUINE; DAPSONE; DOXYCYCLINE; FANSIDAR; MALOPRIM; MEFLOQUINE; PROGUANIL; PYRIMETHAMINE; SULFADOXINE; UNCLASSIFIED DRUG; VIBRADOX;

GASTROINTESTINAL SYMPTOM; HUMAN; MALARIA; MALARIA CONTROL; MENTAL DISEASE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; REVIEW; SKIN TOXICITY;

ANTIMALARIALS; HUMANS; MALARIA;

EID: 0030963573     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Phillips-Howard PA, West LJ. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. J R Soc Med 1990; 83: 82-5.
2. Gaarslev K, Petersen E, Plesner AM, Gade K. Vaccinationsforslag ved udlandsrejse 1997, del I og II. EPI-NYT 1996; 46a & b: 1-4.
3. Høgh B. Clinical and parasitological studies on immunity to Plasmodium falciparum Malaria in children. Scand J Infect Dis Suppl 1996; 102.
4. Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ. Risk of malaria in British residents returning from malarious areas. BMJ 1990; 300: 499-503.
5. Phillips-Howard PA, Bradley DJ, Blaze M. Hurn M. Malaria in Britain: 1977-86. BMJ 1988; 296: 245-8.
6. Behrens RH, Roberts JA. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A and typhoid in travellers. BMJ 1994; 309: 918-22.
7. Baudon D. Malaria and travelers - practical aspects. Trop Med Parasitol 1993; 44: 246-9.
8. Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagenhauf P et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 1993; 341: 1299-303.
9. Lewis SJ, Davidson RN, Ross EJ, Hall AP. Severity of imported falciparum malaria: effect of taking antimalarial prophylaxis. BMJ 1992; 305: 741-3.
10. Hill DR, Behrens RH, Bradley DJ. The risk of malaria in travellers to Thailand. Trans R Soc Trop Med Hyg 1996; 90: 680-1.
11. Bruce-Chwatt LJ, Black RH, Canfield CJ, Clyde DF, Peters W, Wernsdorfer WH. Chemotherapy of malaria. WHO Monograph Series no. 27. Geneva: WHO, 1986.
12. Coatney GR. Pittfalls in a discovery: the cronicle of chloroquine. Am J Trop Med Hyg 1963; 12: 121-8.
13. Center for Disease Control. Chloroquine-resistant malaria acquired in Kenya and Tanzania - Denmark, Georgia. MMWR 1978; 27: 463-4.
14. Lindquist NG. Accumulation of drugs on melanin. Acta Radiol 1973; 325: 1-9.
15. Gustavsson LL, Lindstr̈m B, Grahnén A, Alvén G. Chloroquine excretion following malaria prophylaxis. Br J Clin Pharmacol 1987; 29: 221-4.
16. Wolfe MS, Cordero JF. Safety of chloroquine in chemosuppression of malaria during pregnancy. BMJ 1985; 290: 1466-7.
17. Phillips-Howard PA, Kuile FO. CNS adverse events associated with antimalarial agents. Drug Saf 1995; 12: 370-83.
18. Baker H. The influence of chloroquine and related drugs on psoriasis and keratoderma blennorrhagicum. Br J Dermatol 1996; 78: 161-3.
19. Hatton CS, Peto TE, Bunch C, Pasvol G, Russell SJ, Singer CR et al. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1986; I: 411-4.
20. Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1996; 90: 415-7.
21. Mimica I, Fry W, Eckert G, Schwartz DE. Multiple-dose kinetic study of mefloquine in healthy male volunteers. Chemotherapy 1983; 29: 184-7.
22. Rombo L, Angel VH, Friman G, Hellgren U, Mittelholzer ML, Stürchler D. Comparative tolerability and kinetics during long-term intake of lariam and fansidar for malaria prophylaxis in nonimmune volunteers. Trop Med Parasitol 1993, 44: 254-6.
23. Wetsteyn JCFM, Cobelens FGJ, Kager PA, Eggelte TA. Is mefloquine prophylaxis ineffective for short-term travellers? Lancet 1995; 346: 574.
24. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 1994; 14: 131-45.
25. WHO. International travel and health. Vaccination requirements and health advice. Geneva: WHO, 1996.
26. Hennequin C, Bourée P, Bazin N, Bisaro F, Feline A. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine. Arch Intern Med 1994; 154: 2360-2.
27. Weinke T, Trautmann M, Held T, Weber G, Eichenlaub D, Fleischer K et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 1991; 45: 86-91.